Rising Star: Sullivan & Cromwell's RuiHui 'Rachel' Yu
RuiHui "Rachel" Yu of Sullivan & Cromwell LLP helped Chinese biotechnology company MediLink Therapeutics craft an agreement granting Roche exclusive rights to commercialize its lead antibody-drug conjugate outside China, earning her...To view the full article, register now.
Already a subscriber? Click here to view full article